Skip to the content

  Physician Finder
  eIFU's
  •    Get in Touch
    • General Inquiries
    • Brachytherapy Inquiries
    • radioisotope Inquiries
logo mainlogo darklogo light
  • Radioisotopes CMO
    • The Theragenics Solution
    • Radioisotope CMO Inquiries
  • Brachytherapy Solutions
    • Therapies & Procedures
      • Brachytherapy
      • Fiducial Markers
      • Product Catalog
    • Customer Support
      • eIFU Links
      • Brachytherapy Inquiries  
  • Patient Education
    • Patient Education Videos
    • Prostate Cancer Home
    • About the Prostate & Cancer
    • Risk Factors and Symptoms
    • Screening & Diagnosis
    • Talk to Physicians & Others
    • Treatment Options
    • Prostate Seed Brachytherapy
    • Physician Finder
    • Abbreviated Glossary
  • About Us
    • Our History
    • News & Events
    • Careers
    • Get in Touch  
logo main
  • Radioisotopes CMO
    • The Theragenics Solution
    • Radioisotope CMO Inquiries
  • Brachytherapy Solutions
    • Therapies & Procedures
      • Brachytherapy
      • Fiducial Markers
      • Product Catalog
    • Customer Support
      • eIFU Links
      • Brachytherapy Inquiries  
  • Patient Education
    • Patient Education Videos
    • Prostate Cancer Home
    • About the Prostate & Cancer
    • Risk Factors and Symptoms
    • Screening & Diagnosis
    • Talk to Physicians & Others
    • Treatment Options
    • Prostate Seed Brachytherapy
    • Physician Finder
    • Abbreviated Glossary
  • About Us
    • Our History
    • News & Events
    • Careers
    • Get in Touch  

April 2026

Home2026
Theragenics Brachytherapy Heads to the LUGPA 2026 ASC Academy!
Events

Theragenics Brachytherapy Heads to the LUGPA 2026 ASC Academy!

tgx-admin
April 6, 2026
Theragenics and Clarity Pharmaceuticals Partner to Enable Scalable Copper-64 Supply for Next-Generation Diagnostics
News Press Releases

Theragenics and Clarity Pharmaceuticals Partner to Enable Scalable Copper-64 Supply for Next-Generation Diagnostics

tgx-admin
March 25, 2026
Randomized Trial Supports Dose-De-Escalated Pd-103 LDR Brachytherapy for Low-Risk Prostate Cancer
News

Randomized Trial Supports Dose-De-Escalated Pd-103 LDR Brachytherapy for Low-Risk Prostate Cancer

tgx-admin
January 7, 2026

Latest Post

Theragenics Brachytherapy Heads to the LUGPA 2026 ASC Academy!
Events
Theragenics Brachytherapy Heads to the LUGPA 2026 ASC Academy!
tgx-admin
April 6, 2026
Subscribe to our Knowledge Hub
Subscribe
Theregenics
  • 5203 Bristol Industrial Way
    Buford, Georgia 30518
  • 770.831.5137

Subscribe to our Knowledge Hub

Company

  • About Us
  • History
  • News & Events
  • Careers
  • Get in Touch   

Theragenics subsidiaries

  • Galt Medical Dealer and OEM
  • ArroTek

Radioisotopes CMO

  • Radioisotopes CMO
  • The Theragenics Solution
  • Radioisotope Inquiries   

Brachytherapy Solutions

  • Brachytherapy
  • Fiducial Markers
  • eIFU Links
  • Brachytherapy Inquiries   

For Patients & Caregivers

  • Prostate Cancer Home
  • About the Prostate & Cancer
  • Risk Factors and Symptoms
  • Talk to a Physician
  • Screening & Diagnosis
  • Treatment Options
  • Prostate Seed Brachytherapy
  • Physician Finder  
  • Abbreviated Glossary

Terms & Conditions  |   Privacy Policy  |   Copyright Policy
© 2025 Theragenics Corporation, All Rights Reserved.

Back to top Drag

Subscribe to the Theragenics Knowledge Hub

Receive our latest news and updates right to your inbox.

    Select all communications you would like to receive.


    By filling in and submitting this form, you agree to allow Theragenics to send you emails about its products, services, and content that may be of interest to you. You can withdraw your consent at any time as outlined in our Privacy Notice. By clicking submit, you confirm your agreement to these terms and that you have read and understood the Terms and Conditions, Privacy Notice, and Cookie Notice.